Anacalypsis Therapeutics has raised EUR 300,000 in pre-seed funding from Metavallon VC through its Brain Gain Fund, the first investment by a Greece-based VC fund in a homegrown drug-discovery biotech. The funding will advance AT001, a peptide targeting the LRRK2 pathway as a potential disease-modifying treatment for Parkinson’s disease, through key preclinical proof-of-concept studies.

Causaly has announced a collaboration with Microsoft that brings scientific computation and scientific interpretation together in a single, evidence-grounded workflow for life sciences R&D. The solution links Microsoft Discovery’s analytics, prediction and simulation capabilities with Causaly’s knowledge-graph reasoning, supporting work such as target identification, biomarker strategy and safety assessment.

EBO has secured an investment from Olea Venture Partners, to support the next phase of its growth. EBO's platform automates complex patient interactions such as appointment management, self-assessments and pathway communications. The funding will accelerate adoption across health systems, extend the platform to new clinical and operational workflows, and support further expansion across Europe and into the United States.

finmid has raised €17 million in a round led by Big Pi Ventures, bringing its total funding to EUR 52 million and setting up a new hub in Athens. The Berlin-based embedded lending company is launching vehicle financing with Bolt and a merchant lending program with Skroutz, funded directly by the marketplace for its roughly 9,000 merchants.

Mind The Hack is the only Greece-based company on the Sifted 250 list for 2026, which ranks Europe’s fastest-growing startups. Founded in 2023, the cybersecurity company has built an AI-powered platform that automates penetration testing and continuous vulnerability management, cutting assessment times from weeks to hours.

Omilia has secured $67 million in Series B funding to accelerate the global expansion of its self-learning agentic customer experience platform. The Athens- and New York-based company has grown its annual recurring revenue more than tenfold since its Series A to over $60 million, and runs some of the largest voice AI deployments in production, including a US bank handling more than one million calls a day.

Piney, a Cyprus-founded cleaning and operations provider for short- and mid-term rental property managers, has raised EUR 1.6 million in a round led by Uni.fund. Serving some 5,000 properties across Spain, Portugal, Greece, Cyprus, France and the US, the company will use the funds to expand its AI capabilities and grow beyond Europe, starting with Miami.

ReNeuroCell Therapeutics, a Heraklion-based spin-off of IMBB-FORTH and the University of Crete, has secured a EUR 500,000 grant from the European Innovation Council’s EIC Pre-Accelerator program. The company is developing human neuroimplants for patients with spinal cord injuries. The funding will strengthen its intellectual property and prepare it to attract venture capital and apply for EIC Accelerator funding of up to EUR 2.5 million.